April 1, 2019
Rgenix To Present Abstract on RGX-019 at the 2019 AACR Annual Meeting
NEW YORK–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/biotech?src=hash" target="_blank"gt;#biotechlt;/agt;–Rgenix, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and antibody cancer therapeutics, announced…